Gene duplication confers genetic redundancy that can facilitate subfunctionalization, the partitioning of ancestral functions between paralogs. We capitalize on a recent genome duplication in Xenopus laevis (African clawed frog) to interrogate possible functional differentiation between alloalleles of the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor that mediates toxicity of dioxin-like compounds and plays a role in the physiology and development of the cardiovascular, hepatic, and immune systems in vertebrates. X. laevis has 2 AHR genes, AHR1a and AHR1b. To test the hypothesis that the encoded proteins exhibit different molecular functions, we used TALENs in XLK-WG cells, generating mutant lines lacking functional versions of each AHR and measuring the transcriptional responsiveness of several target genes to the toxic xenobiotic 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the candidate endogenous ligand 6-formylindolo[3,2-b]carbazole (FICZ). Mutation of either AHR1a or AHR1b reduced TCDD induction of the canonical AHR target, Cytochrome P4501A6, by 75%, despite the much lower abundance of AHR1b in wild-type cells. More modestly induced target genes, encoding aryl hydrocarbon receptor repressor (AHRR), spectrin repeat-containing nuclear envelope protein 1 (SYNE-1), and gap junction protein gamma 1 (GJC1), were regulated solely by AHR1a. AHR1b was responsible for CYP1A6 induction by FICZ, while AHR1a mediated FICZ induction of AHRR. We conclude that AHR1a and AHR1b have distinct transcriptional functions in response to specific agonists, even within a single cell type. Functional analysis of frog AHR paralogs advances the understanding of AHR evolution and as well as the use of frog models of developmental toxicology such as FETAX.
The aryl hydrocarbon receptor (AHR) is a nuclear receptor best known for mediating the toxic effects of environmental contaminants. Potent xenobiotic agonists include 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) and structurally related halogenated aromatic hydrocarbons as well as polynuclear aromatic hydrocarbons such as benzo(a)pyrene (BaP; Denison et al., 2011) . The AHR also plays important roles in a wide range of vertebrate developmental and physiological processes (Gasiewicz and Henry, 2012) , presumably through the action of endogenous ligands (Denison et al., 2011) . 6-formylindolo [3,2-b] carbazole (FICZ), produced from tryptophan as a photoproduct, a result of oxidizing conditions, or as a metabolic product (Smirnova, 2016) , is a wellcharacterized candidate endogenous agonist that exhibits even higher affinity for AHR than does TCDD (Laub et al., 2010; Wincent et al., 2009) . The most prominent result of AHR activation is induced expression of the Cytochrome P4501A (CYP1A) subfamily of phase I detoxification enzymes (Hankinson, 1995) , but numerous other transcripts are also altered directly or indirectly (eg, Frueh et al., 2001; Puga et al., 2000) . AHR also functions through cross-talk with additional nuclear receptors and signaling pathways (eg, Carlson and Perdew, 2002; Matsumura, 2012; Puga et al., 2005) .
AHR sequences are widely conserved across vertebrate lineages, but species differ in paralog number. Humans and rodents harbor a single AHR gene, which is required for toxicity of TCDD and BaP (Fernandez-Salguero et al., 1996; Mimura et al., 1997; Shimizu et al., 2000) . In contrast, most vertebrates have 2 or more AHRs, products of ancient or recent gene duplications. AHR2, a second AHR gene, was first observed in fish (Hahn et al., 1997) and subsequently in birds (Yasui et al., 2004 (Yasui et al., , 2007 , reptiles (Marquez et al., 2011; Oka et al., 2016) , and some mammals (Hahn and Karchner, 2012) . AHR2 arose from a tandem gene duplication in an early gnathostome ancestor and was later lost in some lineages (Hahn and Karchner, 2012) . Individual species have evolved additional copies of either AHR gene. Zebrafish (Danio rerio) have 2 putative orthologs of human AHR, AHR1a, and AHR1b, along with a single AHR2. Similarly, chicken, American alligator (Alligator mississipiensis), and western painted turtle (Chrysemys picta bellii) genomes contain 2 AHR1 genes plus one AHR2 (Oka et al., 2016; Yasui et al., 2007) . AHR evolution in many fish is even more complex. Atlantic salmon (Salmo salar) harbor 2 AHR1 genes and 4 AHR2s, while the pufferfish (Takifugu rubripes) genome contains 2 AHR1s and 3 AHR2s (Hahn et al., 2006; Hansson et al., 2003 Hansson et al., , 2004 ) . The shark Squalus acanthias has AHR3, a more ancient paralog that was presumably lost in teleosts and tetrapods (Merson et al., 2009) .
TCDD activates AHR1s and AHR2s from many species in vitro (eg, Karchner et al., 1999; Oka et al., 2016; Yasui et al., 2007) , but the in vivo significance of AHR gene multiplicity remains poorly understood. AHR1 sequence signatures predict toxicity of dioxin-like compounds in birds (Farmahin et al., 2013) . In contrast, AHR2 mediates TCDD toxicity in developing zebrafish (Prasch et al., 2003) , even though TCDD is an in vitro AHR1B agonist (Karchner et al., 2005) .
AHRs from the African clawed frog (Xenopus laevis) exhibit unique evolutionary history. Two AHR genes, AHR1a and AHR1b are less divergent than the AHR1 paralogs in other vertebrates, sharing 86% amino acid identity (Lavine et al., 2005; Oka et al., 2016) . Like many X. laevis "alloalleles", they arose in a genome duplication approximately 50 MYA (Evans et al., 2004) . This duplication resulted from interspecies hybridization, producing an allotetraploid species from which X. laevis (and other polyploid members of the genus) evolved (Chain and Evans, 2006; Evans et al., 2004; Hellsten et al., 2007) . The resulting genome contains 2 "subgenomes", each with 9 homeologous chromosomes. The homeolog sets are designated with postfixes "L" and "S" (long and short), recognizing differences in their karyotypic sizes (Matsuda et al., 2015) . AHR1a resides on Chromosome 6L, while AHR1b is on 6S. Recent nomenclature guidelines would designate AHR1a as ahr1.L and AHR1b as ahr1.S (Amaya et al., 2013) . To our knowledge, X. laevis is the only species thus far documented to contain multiple AHR1 paralogs in the absence of AHR2.
As with other AHR gene duplicates, the biological significance of AHR1a and AHR1b is not well understood. The 2 proteins largely share functional characteristics in vitro. TCDD is an agonist for both receptors, although it exhibits 20-to 50-fold lower affinity than for mouse AHR, and corresponding low potency in DNA mobility shift assays and transactivation assays (Lavine et al., 2005) . Conventional wisdom holds that X. laevis alloalleles typically have redundant functions, since emergence of developmental phenotypes often requires morpholino knockdown of both genes (Abu-Daya et al., 2012) . However, some gene duplicates show evidence of functional divergence (Chain and Evans, 2006; Hellsten et al., 2007) . The objective of this study was to test the hypothesis that endogenous AHR1a and AHR1b have different molecular functions in XLK-WG (Martin et al., 1998) , a frog cell line used previously for AHR characterization (Iwamoto et al., 2012; Laub et al., 2010) . Using TALENs, we generated mutant cells lacking either AHR1a or AHR1b, examining the responsiveness of each to a xenobiotic and a candidate endogenous agonist. Our data indicate that even within a single cell type, X. laevis AHRs play distinct roles in the regulation of gene expression following TCDD or FICZ exposure.
MATERIALS AND METHODS
AHR agonists. 2,3,7,8-tetracholordibenzo-p-dioxin (TCDD) was obtained from ULTRA Scientific (North Kingstown, Rhode Island), and FICZ was obtained from Enzo Life Sciences (Farmingdale, New York). These agonists were used at 100 mM in cultures, much higher than is typical for studies of most other vertebrate AHRs, because the frog AHRs have relatively low affinity for TCDD (Lavine et al., 2005) and, to a lesser degree, FICZ (Odio et al., 2013) . The EC 50 for CYP1A6 induction in XLK-WG cells is at least 174 nM for TCDD and 6 nM for FICZ (Laub et al., 2008) .
The XLK-WG model system. XLK-WG cells (ATCC, Manassas, Virginia; (Martin et al., 1998) were cultured as directed by the supplier: 29 C with 5% CO 2 in RPMI-1640 medium (ThermoFisher Scientific, Waltham, MA) with 20% FBS (Invitrogen, Carlsbad, California; Iwamoto et al., 2012; Laub et al., 2010) . Only 2 X. laevis cell lines are publicly available from the ATCC, A6 and XLK-WG. Both are derived from kidney epithelium. Cell line derivations that are more traditional for AHR studies, such as from liver, breast tumors, or the immune system, are not available from this species. Fast growing and easily cared for, XLK-WG cells represent an excellent opportunity to employ the power of a frog tissue culture model to investigate subfunctionalization of the X. laevis AHR paralogs. We have previously pursued their use, publishing characterizations of the expression and function of AHRs along with the genes (Laub et al., 2010) and CYP1 enzyme activities they regulate (Iwamoto et al., 2012) . Further, recent studies in AHR-deficient rats showed several defects related to the development of the kidney (Harrill et al., 2013) Genotyping. Transfected colonies were expanded and lysed overnight at 37 C in lysis buffer (100 mM Tris-HCl pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl, 100 mg/ml proteinase K). DNA was precipitated with isopropanol, washed with 70% EtOH, and suspended in 10 mM Tris-HCl, pH 8.5. Regions of AHR1a or AHR1b containing the TALEN target site were amplified with pfx polymerase (Invitrogen) with gene-specific primers (Table 1) . Amplicons were purified with the MiniElute PCR purification kit (Qiagen, Germantown, Maryland) and cloned into the TOPO-II blunt-end cloning vector (Invitrogen). TOP-10 competent E. coli were transformed according to the instructions of the manufacturer (Invitrogen). Plasmids were purified with the QiaPrep Miniprep Spin Kit (Qiagen) and sequenced (Retrogen, San Diego, California).
qRT-PCR. Relative abundance of mRNAs encoding the AHRs or their target genes was measured in XLK-WG cells by quantitative RT-PCR. Cells were dosed with 100 nM TCDD, 100 nM FICZ, or DMSO vehicle (0.25%). Following a 22-h exposure, total RNA was harvested using QIAshredder and RNeasy spin columns with on-column DNase (Qiagen). Reverse transcription was accomplished with Taqman reverse transcription kit (Applied Biosystems, Foster City, California). cDNAs were amplified in triplicate using Power SYBR Green Maser Mix (Applied Biosystems) on the Applied Biosystems 7500 platform. Amplification of b-actin, CYP1A6, AHR1a, and AHR1b was carried out with 10 ng RNA per reaction; AHRR, SYNE-1, and GJC1 reactions were performed with 40 ng RNA per reaction. Primers sequences are indicated in Table 1 . Cycling conditions were 95 C/10 00 ; [95 C/15 00 , 60 C/60 00 ] for 50 cycles. Data were analyzed with SDS 1.4 software (Applied Biosystems) using the DDCt method with b-actin as endogenous control. Melting point analysis was performed at the conclusion of each reaction to verify the presence of a single amplicon.
Reporter gene assays. Reporter gene assays were conducted essentially as described in previously published studies of frog AHRs (Lavine et al., 2005; Odio et al., 2013) . COS-7 (derived from green monkey kidney; ATCC) have been widely used for many years in functional characterization of heterologously expressed AHRs from various vertebrate groups [eg, Abnet et al., 1999; Karchner, et al. 1999 (fish) ; Lavine et al., 2005 , Shoots et al., 2015 ; Farmahin et al., 2013 (Birds) ]. These cells lack endogenous expression of functional AHR and have very low ARNT activity (Evans et al., 2008; Zimmermann et al., 2008) . Cells were cultured at 37 C with 5% CO 2 in Dulbecco's modified eagle medium (ThermoFisher Scientific) with 10% FBS (Lavine et al., 2005) . Cells were seeded in 48-well plates at 2 Â 10 4 cells/well and cultured overnight. Cells were transiently transfected with the reporter construct pGudLuc6.1, which is driven by a region of the mouse CYP1A1 enhancer containing 4 xenobiotic response elements (XREs; Long et al., 1998) . Transfection was carried out with Lipofectamine 2000 (Invitrogen). To measure transcriptional activity of mutant AHRs, cells were transfected in triplicate with 20 ng pGudLuc6.1, 3 ng of the Renilla luciferase control pRL-TK (Promega), 50 ng ARNT plasmid, and 50 ng of AHR plasmid. The ARNT construct is contained in pSPORT and each AHR in pCMVTNT. Mutant AHR constructs were synthesized by Epoch Life Sciences (Sugar Land, Texas). Five hours after transfection, cells were dosed with 100 nM TCDD or DMSO vehicle (0.6%) and lysed after 18 h of exposure. Transactivation was measured using the Dual Luciferase Reporter Assay Kit (Promega) and TD 20/20 luminometer (Turner Designs, San Jose, California). Transcriptional activity is reported as relative luciferase units (RLUs), given by the ratio of firefly luciferase luminescence to that from Renilla luciferase. To test the hypothesis that the mutant protein AHR1b-B1 functions as a dominant negative, cells were co-transfected with 50 ng AHR1a plasmid and 25, 50, or 75 ng AHR1b-B1 plasmid. All other conditions were maintained as described earlier.
Western blotting. AHR1a and AHR1b proteins were detected using western blotting. XLK-WG ells were grown in 96-well plates and transfected COS-7 cells in 48-well plates as described earlier.
Both were lysed directly in 1X Laemmli buffer (BioRad, Hercules, California; 30 or 45 ml per 3 wells, respectively). Lysates were boiled for 3 min and subjected to SDS-PAGE. Following transfer to nitrocellulouse membrane, blots were probed with antibody SA-210 (Enzo Life Sciences; 1:1000), which was raised against the 402-residue N-terminal portion of mouse AHR b-1 (Pollenz et al 1994) and is cross-reactive with X. laevis AHR1a and AHR1b (Lavine et al., 2005; Odio et al., 2013) . Blots were next probed with goat anti-rabbit alkaline phosphatase (1:1000; Sigma-Aldrich, St Louis, Missouri) and developed with NBT and BCIP in AP buffer (BioRad). In vitro transcribed and translated AHRs were 
RESULTS

TALEN Mutagenesis
XLK-WG cells were transfected with TALEN constructs targeting helix 1 of the basic-helix-loop-helix (bHLH) motif within exon 2 of AHR1a or AHR1b ( Figure 1A ). Transfection elicited a 4 and 6 bp deletion in the TALEN target site of AHR1a in the strain designated A3 ( Figure 1B) . The mutant allele, termed AHR1a-A3, encodes a truncated protein with a premature stop codon. We also identified a 21 bp deletion in AHR1b of the strain B1, which removes 7 amino acid residues (45-51; Figure 1B ). For each strain, the wild-type sequence of the non-targeted AHR was verified by sequencing. With the aim of generating a double AHR mutant, we transfected A3 cells with the TALEN pair targeted to AHR1b or, alternatively, targeted AHR1a in the AHR1b-mutant background; however, cells transfected to target both AHR alloalleles consistently failed to proliferate following transfection and under conditions of clonal dilution.
AHR Expression in Mutant Cell Lines
Quantification of relative mRNA expression in wild-type XLK-WG cells indicated that AHR1a is approximately 3-fold more abundant than AHR1b Figure 2A ). Western blotting ( Figure 2B ) supported this finding, with a more intense band for AHR1a protein (94.2 kDa) than for AHR1b (93.6 kDa). As predicted, AHR1a protein was not detectable in mutant strain A3. In strain B1, expression of AHR1b protein persisted, retaining immunoreactivity despite the TALEN-induced deletion of 7 amino acids within the 402-residue SA-210 epitope ( Figure 2B ). Mutagenesis of AHR1a or AHR1b altered expression of both the mutated mRNA and the wild-type paralog in different ways. AHR1a mRNA was 36% less abundant in the A3 line than in wild type cells ( Figure 2C ; 1-way ANOVA, P ¼ .0431, n ¼ 5), while AHR1b mRNA expression was elevated 75% ( Figure 2D : 1-way ANOVA, P ¼ .0110, n ¼ 4). In contrast, mutation of AHR1b did not affect expression of either AHR transcript. 
Transcriptional Activity of Mutant AHRs
Transcriptional activity of mutant AHRs was assessed using transactivation assays in COS-7 cells treated for 18 h with 100 nM TCDD. High TCDD concentrations in this and subsequent experiments were necessary due to the relatively low TCDD binding affinity of AHRs from X. laevis and other amphibians (Laub et al., 2010; Lavine et al., 2005; Shoots et al., 2015) . Neither AHR1a-A3 nor AHR1b-B1 was able to induce XRE-driven luciferase expression from the pGudLuc6.1 reporter plasmid (Figs. 3A and B ). This result, expected for the substantially truncated AHR1a mutant, was an important demonstration that the 7-residue deletion in helix 1 of AHR1b renders the protein inactive. We remained concerned that mutant AHR1b could function as a dominant negative. This possibility was addressed with a similar transactivation assay, reasoning that if AHR1b-B1 functions as a dominant negative, increasing its quantity should diminish transcription activation by wild-type AHR1a. Instead, the presence of mutant AHR1b left luciferase induction by AHR1a unaffected, demonstrating that the mutant protein does not act in dominant negative fashion (Figs. 3C and D) .
Target Gene Induction by TCDD
To test the functional consequence of AHR1a and AHR1b mutation, we used qPCR to measure expression of the AHR target gene CYP1A6 (Fujita et al., 1999; Iwamoto et al., 2012) , comparing wild-type and mutant XLK-WG cells following 22-h exposure to 100 nM TCDD. Mutation of either AHR had a similar effect on CYP1A6 induction, diminishing mRNA abundance by approximately 75% in TCDD-exposed cells ( Figure 4A , 2-way ANOVA. P ¼ .03, n ¼ 3). This outcome suggests that both AHRs are essential for maximal induction of this target gene. To mimic double AHR knockout, AHR1b mRNA was depleted by siRNA knockdown in the AHR1a-mutant background. In wild-type cells, AHR1b expression was reduced by siAHR1b but not by a NTC, illustrating the efficacy of siAHR1b ( Figure 4B ). Following TCDD exposure, CYP1A6 induction in NTC-treated A3 cells was reduced 77% compared with wild-type cells ( Figure 4C , 2-way ANOVA. P < .0001, n ¼ 3). siRNA depletion of AHR1b in wild-type cells diminished responsiveness by 59%, while AHR1b knockdown in A3 cells reduced CYP1A6 induction by 93%. Thus, dual depletion of AHR1a and AHR1b abrogates nearly all CYP1A6 induction by TCDD. A, qPCR. Total RNA was harvested from wild-type cells and reverse transcribed. mRNA abundance was measured in triplicate using qPCR with b-actin as endogenous control. n ¼ 3. Representative experiment is depicted. B, Western blot. Cell lysate was subjected to SDS-PAGE, transferred to nitrocellulose, and probed with primary antibody SA-210 (1:1000; Enzo) directed against the N-terminal region of AHR1a (94.2 kDa) and AHR1b (93.6 kDa). AHR protein standards were generated by in vitro transcription using the TNT Quick-coupled Transcription/Translation kit (Promega). C and D, qPCR was accomplished as described. mRNA expression is reported relative to wild-type cells. C, AHR1a. One-way ANOVA with Tukey's multiple comparisons test. p ¼ .043. n ¼ 5 biological replicates. D, AHR1b. One-way ANOVA with Tukey's multiple comparisons test. P ¼ .011. n ¼ 4 biological replicates. Error bars ¼ SEM. *P < .05.
To discern potential differences in the transcriptional functions of X. laevis AHRs, we assayed expression of several additional TCDD-responsive target genes identified in a previous microarray study of XLK-WG cells (Laub et al., 2010) . Expression of Aryl hydrocarbon receptor repressor (AHRR), a negative regulator of AHR (Mimura et al., 1999; Zimmermann et al., 2008) , was diminished 70% by AHR1a mutation. AHR1b mutation did not affect AHRR induction ( Figure 5A , 2-way ANOVA, P ¼ .043, n ¼ 3). Spectrin repeat-containing nuclear envelope protein 1 (SYNE-1), which encodes a nuclear envelope protein (Muchir and Worman, 2007; Puckelwartz et al., 2009 ), was induced 6.2-fold by TCDD in wildtype cells. While AHR1b mutation did not affect SYNE-1 mRNA following TCDD treatment, mutation of AHR1a diminished TCDD induction by 74% ( Figure 5B , 2-way ANOVA, P ¼ .0066, n ¼ 3). Responsiveness of Gap junction protein gamma 1 (GJC1), which encodes a connexin protein (Kanter et al., 1994) reflected that of AHRR and SYNE-1; GJC1 induction by TCDD was sensitive to mutation of AHR1a alone ( Figure 5C ). AHR1a is primarily responsible for induction of these transcriptional targets in response to TCDD.
Target Gene Induction by FICZ
We next sought to examine the transcriptional response of AHR mutant cell lines to FICZ, a candidate endogenous ligand for the AHR that is derived from tryptophan. It binds with higher affinity than TCDD, but unlike the toxicological agonist, it is readily metabolized by the CYP1 enzymes that such binding induces (Wincent et al., 2009) . Target gene induction was monitored in mutant and wild-type XLK-WG cells by qPCR following 22-h exposure to 100 nM FICZ. AHR1b mutation diminished CYP1A6 induction by 76%; however, CYP1A6 induction by FICZ was insensitive to mutation of AHR1a ( Figure 6A , 2-way ANOVA, P ¼ .0091, n ¼ 3), indicating that AHR1b, not AHR1a, mediates FICZ induction of CYP1A6. The relatively modest (40-fold) induction of CYP1A6 in B1 cells suggests that FICZ weakly promotes AHR1a-mediated induction of CYP1A6 in the absence of functional AHR1b. To determine whether AHR1b regulates expression of other target genes following FICZ treatment, we assayed expression of AHRR mRNA. Mutation of AHR1a reduced AHRR induction by 71% compared with wild-type cells, while AHR1b mutation had no effect ( Figure 6B , 2-way ANOVA, P ¼ .0014, n ¼ 4). In contrast to CYP1A6 induction, AHRR induction by FICZ is driven primarily by AHR1a.
The minimal effect of AHR1a mutation on FICZ-induced CYP1A6 expression was surprising. To further interrogate the function of FICZ as an AHR1a agonist for CYP1A induction, we monitored reporter gene induction by each AHR following 18-h exposure to 100 nM FICZ. In this heterologous context, AHR1a readily mediated transcription of luciferase expression in pGudLuc6.1, driven by the mouse CYP1A1 enhancer (Long et al., 1998) , in the absence of AHR1b Figure 7) . Thus, endogenous enhancer elements and a native chromatin context, lacking in the transfected reporter gene, likely play an important role in the distinct activities of the paralogous frog AHRs.
DISCUSSION
AHR Gene Editing
We report the development of 2 strains derived from X. laevis XLK-WG cells lacking functional AHR1a or AHR1b. In contrast to the strain A3, which harbors a premature stop codon early in the AHR1a coding region, the AHR1b-mutant (B1) bears a deletion of only 7 amino acid residues. In multiple attempts to produce a cell line bearing an early nonsense mutation in AHR1b, we observed a disproportionate number of in-frame deletions. Thus, we proceeded with characterization of the AHR1b-B1 strain. This cell line harbors a homozygous deletion within the highly conserved N-terminal region of AHR1b, removing a portion of helix 1 of the bHLH domain (Fukunaga et al., 1995; Lavine et al., 2005) . Deletion mutagenesis of mouse AHR has demonstrated that helix 1 is essential for several AHR functions, including HSP90 binding, dimerization with ARNT, and DNA binding (Fukunaga et al., 1995) . As this previous study predicts, AHR1b-B1 exhibited no agonist-induced activity in transactivation assays. We also considered the possibility that AHR1b-B1 could function as a dominant negative, but reporter gene induction by AHR1a was not reduced by AHR1b-B1 expression following TCDD treatment. Together, these assays indicate that the B1 cell line represents a sound model for characterization of endogenous AHR1a function in an isolated context, despite a lack of an early nonsense mutation in AHR1b.
Additional challenges to our gene editing workflow included the difficulty of generating bi-allelic mutations and achieving strain clonality. In our hands, neither TALEN pair reliably cleaved both alleles of an AHR paralog in a single cell; many resulting strains bore a mutation in only one gene copy. Further, in several isolates, we detected more than 2 distinct indels. The complex mixture of indels and wild-type alleles we found in many strains likely resulted from a combination of both incomplete cutting and TALEN activity in daughter cells, following division of the single cell progenitor. Similarly, zinc finger nucleases can elicit both heterozygous and homozygous mutations in cultured mammalian cells (Liu et al., 2010; Santiago et al., 2008) , and TALEN gene editing in mouse embryos produces heterozygous and mosaic mice (eg, Davies et al., 2013; Sung et al., 2013) . To verify clonality, mutant strains were subjected to 2 rounds of clonal dilution and genotyping. The additional clonal dilution step also ensured that mutant strains were not contaminated by wild-type cells not previously excluded.
Given the error-prone nature of non-homologous end-joining (NHEJ), we anticipated that TALEN activity would elicit the presence of 2 distinct indels ('complex heterozygosity'). However, both AHR1a -A3 and AHR1b-B1 were homozygous for their respective mutations. We suggest that this outcome involves homologous recombination rather than independent, identical NHEJ events, as observed in other systems (Carlson et al., 2012; Urnov et al., 2005) . Responding to initial double-strand break, the NHEJ repair process generates an indel at a cleaved target site. Following TALEN cleavage of the second gene copy, the mutant allele serves as a template for homologous recombination, replicating the indel during homologydirected repair.
Transcriptional Compensation for AHR Mutation
As an additional measure of mutant cell line characterization, we quantified relative abundance of AHR mRNAs in each strain. In comparison to wild-type cells, AHR1a-A3 mRNA expression was reduced, likely a consequence of nonsense-mediated messenger decay (Baker and Parker, 2004) . In contrast, AHR1b mRNA was 75% more abundant in A3 cells than in wild-type XLK-WG, accompanied by an apparent increase in AHR1b protein. We hypothesize that elevated AHR1b expression reflects a compensatory response to the loss of functional AHR1a. A similar outcome was recently documented following TALEN mutagenesis in zebrafish. Mutation of EGF-like-domain multiple 7 (egfl7) induced upregulation of functionally related emilin genes that covered egfl7 mutation (Rossi et al., 2015) . Elevated AHR1b expression in A3 cells was not sufficient to cover the AHR1a mutation, though it may limit our ability to quantitatively describe the respective functions of each AHR. Compensation following AHR1b mutation was not detected. We speculate that differential regulation of AHR expression relates to the distinct type of mutation in each mutant strain; a compensatory regulatory program may be responsive to a premature stop codon but not to an in-frame deletion. To our knowledge this is the first observation of genetic compensation to a deleterious mutation in Xenopus, one that may have broad implications for the penetrance of phenotypes resulting from genome editing in frogs, especially the pseudotetraploid X. laevis.
Enhancer-Specific AHR Paralog Function
Despite the loss of only a small fraction of the overall pool of AHR protein, AHR1b mutation abrogated CYP1A6 induction to a level rivaling mutation of AHR1a. This suggests that AHR1b is more efficacious than AHR1a for this transcriptional response, playing an outsized role in regulation of CYP1A6 induction by TCDD. In contrast, AHR1b mutation did not affect regulation of 3 additional target genes: AHRR (a well-characterized AHR target; Zimmermann et al., 2008) plus SYNE-1 and GJC1 (previously identified in a microarray screen of TCDD-and FICZ-treated XLK-WG cells; Laub et al., 2010) . AHR1a alone was sufficient to mediate their induction. Differential strength of cis-regulatory features may underlie this discrepancy. Relative to CYP1A6, induction of AHRR, SYNE-1, and GJC1 is modest. While the extraordinary strength of the CYP1A6 promoter/enhancer region enables productive interaction with both AHR1a and AHR1b, the relevant enhancer regions of more modestly induced target genes are presumably weaker, exacerbating differences in the ability of each AHR to upregulate transcription. Overall, these data suggest that AHR1a and AHR1b differentially regulate target gene induction in response to TCDD. AHR paralogs in other species and contexts also exhibit divergent transcriptional activities. For instance, rainbow trout AHR2a and AHR2b differentially induce reporter genes driven by distinct cis-regulatory regions following TCDD treatment (Abnet et al., 1999) .
Functional Differentiation of AHR Alloalleles
AHR1a and AHR1b have adopted distinct transcriptional regulatory functions in a single cell type, suggesting that AHR target genes are partitioned between the 2 proteins. This case is illustrated by responsiveness to FICZ, in which CYP1A6 induction is mediated by AHR1b while AHR1a drives AHRR induction. Many pairs of alloalleles are retained in X. laevis, a consequence of several potential mechanisms that are not mutually exclusive. These include spatiotemporal subfunctionalization, neofunctionalization, complementary degeneration of functional domains, and maintenance of post-duplication stoichiometry (Chain and Evans, 2006; Hellsten et al., 2007) Five hours after transfection, cells were treated with 100 nM FICZ or DMSO (0.6%) for 18 h. Transcriptional activity was measured in triplicate using a luciferase reporter gene driven by a portion of the mouse CYP1A1 enhancer.
Transactivation is given by the ratio of reporter-derived luciferase luminescence to constitutively expressed control Renilla luciferase luminescence, reported as RLUs. n ¼ 2 biological replicates. Representative experiment is depicted. Error bars ¼ SEM.
which gene duplicates most typically adopt complementary spatiotemporal expression patterns (Force et al., 1999) . Functional differentiation of gene duplicates provides an opportunity to discern general properties of multifunctional proteins following distribution of functions between each copy. This study demonstrated the subfunctionalization of 2 X. laevis alloalles within a single cell type. However, the in vivo relevance of XLK-WG, an immortalized cell line, remains unclear, and while functional AHR is expressed in these cells, their derivation from kidney epithelium leaves the toxicological significance of our observations for classical target organs of AHR agonists, like liver, uncertain. Potential functional divergence of AHR1a and AHR1b in a cell line nonetheless establishes the rationale for a similar study in AHR-mutant frogs. Such studies will reveal whether target gene preferences for AHR1a and AHR1b underlie mutant phenotypes, enabling a better understanding of the transcriptional regulatory functions and targets that govern both xenobiotic toxicity and normal development in conjunction with each AHR in specific tissues.
AHRs from frogs (and other amphibians) have exceptionally low affinity for xenobiotic agonists, a trait that underlies the relatively low toxicity of such compounds in this animal group (Jung and Walker, 1997; Lavine et al., 2005; Shoots et al., 2015) . The presence of multiple, subfunctionalized AHRs represents a second important difference in this signaling pathway between frogs and humans. A clear understanding of mechanistic differences in toxic mechanisms between X. laevis and humans contributes to a more refined and accurate use of this species as a model for vertebrate development and developmental toxicology, especially in toxicity testing regimes such as the Frog Embryo Teratogenesis Assay-Xenopus (FETAX; ASTM, 2012; Hoke and Ankley, 2005) .
